The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis
Open accessAbstract
BACKGROUND: In patients with decreased resistance to infection, Staphylococcus aureus is a major cause of bacteremia and its complications. The capsular polysaccharides are essential for the pathogenesis of and immunity to S. aureus infection and are targets for vaccines. METHODS: In a double-blind trial involving patients with end-stage renal disease who were receiving hemodialysis, we evaluated the safety, immunogenicity, and efficacy of a vaccine with S. aureus type 5 and 8 capsular polysaccharides conjugated to nontoxic recombinant Pseudomonas aeruginosa exotoxin A. Between April 1998 and August 1999, 1804 adult patients at 73 hemodialysis centers were randomly assigned to receive a single intramuscular injection of either vaccine or saline. IgG antibodies to S. aureus type 5 and 8 capsular polysaccharides were measured for up to two years, and episodes of S. aureus bacteremia were recorded. Efficacy was estimated by comparing the incidence of S. aureus bacteremia in the patients who received the vaccine with the incidence in the control patients. RESULTS: Reactions to the vaccine were generally mild to moderate, and most resolved within two days. The capsular polysaccharides elicited an antibody response of at least 80 microg per milliliter (the estimated minimal level conferring protection) in 80 percent of patients for type 5 and in 75 percent of patients for type 8. The efficacy during weeks 3 to 54 was only 26 percent (P=0.23). However, between weeks 3 and 40 after vaccination, S. aureus bacteremia developed in 11 of 892 patients in the vaccine group who could be evaluated for bacteremia, as compared with 26 of 906 patients in the control group (estimate of efficacy, 57 percent; 95 percent confidence interval, 10 to 81 percent; nominal P=0.02). CONCLUSIONS: In patients receiving hemodialysis, a conjugate vaccine can confer partial immunity against S. aureus bacteremia for approximately 40 weeks, after which protection wanes as antibody levels decrease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Nosocomial infections in medical intensive care units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999) · Critical Care Medicine · doi:10.1097/00003246-199905000-00020 · Cited by 1,565
Emergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., & Moiduddin, A. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990102 · Cited by 445
Robbins, J. B., Parke, J. C., Schneerson, R., & Whisnant, J. K. (1973) · Pediatric Research · doi:10.1203/00006450-197303000-00001 · Cited by 291
Self-citationAssessment of the Antibody Response to Pneumococcal Vaccine in High-Risk Populations
Landesman, S. H., & Schiffman, G. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_1.s184 · Cited by 199
Fattom, A. I., Sarwar, J., Ortiz, A., & Naso, R. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1659-1665.1996 · Cited by 175
Self-citationArbeit, R. D., Karakawa, W. W., Vann, W. F., & Robbins, J. B. (1984) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(84)90002-6 · Cited by 175
Self-citationFattom, A., Schneerson, R., Watson, D. C., Karakawa, W. W., FitzGerald, D., Pastan, I. H., Li, X., Shiloach, J., Bryla, D. A., & Robbins, J. B. (1993) · Infection and Immunity · doi:10.1128/iai.61.3.1023-1032.1993 · Cited by 136
Self-citation
Cited by
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0147-4 · Cited by 2,051
Methicillin-resistant Staphylococcus aureus
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.33 · Cited by 1,556
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 932
Moreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaun, E., Pettersson, G. B., Schäfers, H. J., & Prendergast, B. D. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 715
Staphylococcal manipulation of host immune responses
Thammavongsa, V., Kim, H. K., Missiakas, D., & Schneewind, O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3521 · Cited by 598
Staphylococcus aureus Capsular Polysaccharides
O'Riordan, K., & Lee, J. C. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.218-234.2004 · Cited by 586
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
“to examine the role of newer antibiotics and topical agents in the treatment of MRSA infections and colonization; and to pursue development and testing of an S aureus vaccine.(58)”
BackgroundMethicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Deresinski, S. (2005) · Clinical Infectious Diseases · doi:10.1086/427701 · Cited by 466
Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight Infants
Kaufman, D., & Fairchild, K. D. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.3.638-680.2004 · Cited by 435
Delany, I., Rappuoli, R., & De Gregorio, E. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403876 · Cited by 420
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Fowler, V. G., Allen, K. B., Moreira, E. D., Moustafa, M., Isgro, F., Boucher, H. W., Corey, G. R., Carmeli, Y., Betts, R., Hartzel, J. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.3010 · Cited by 372
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318535 · Cited by 369
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia
Kollef, M. H. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000128569.09113.fb · Cited by 366
Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections
Kluytmans, J. A. J. W., & Wertheim, H. F. L. (2005) · Infection · doi:10.1007/s15010-005-4012-9 · Cited by 360
Clinical Predictors of Major Infections After Cardiac Surgery
Fowler, V. G., O’Brien, S. M., Muhlbaier, L. H., Corey, G. R., Ferguson, T. B., & Peterson, E. D. (2005) · Circulation · doi:10.1161/circulationaha.104.525790 · Cited by 354
Mechanisms of Antibiotic Resistance in Staphylococcus Aureus
Pantosti, A., Sanchini, A., & Monaco, M. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.323 · Cited by 348
The Role of Macrophages in Staphylococcus aureus Infection
Pidwill, G. R., Gibson, J. F., Cole, J., Renshaw, S. A., & Foster, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620339 · Cited by 341
Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
Ishani, A., Collins, A. J., Herzog, C. A., & Foley, R. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00414.x · Cited by 313
Vaccine assembly from surface proteins of Staphylococcus aureus
Stranger-Jones, Y. K., Bae, T., & Schneewind, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606863103 · Cited by 309
Saiman, L. (2003) · American Journal of Infection Control · doi:10.1067/mic.2003.78 · Cited by 307
Pathogenesis of Staphylococcus aureus Bloodstream Infections
Thomer, L., Schneewind, O., & Missiakas, D. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044351 · Cited by 292
Current Management of Vascular Access
Allon, M. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00860207 · Cited by 289
The changing face of infective endocarditis
Prendergast, B. D. (2006) · Heart · doi:10.1136/hrt.2005.067256 · Cited by 277
Kuklin, N. A., Clark, D. J., Secore, S., Cook, J., Cope, L. D., McNeely, T., Noble, L., Brown, M. J., Zorman, J. K., Wang, X. M., et al. (2006) · Infection and Immunity · doi:10.1128/iai.74.4.2215-2223.2006 · Cited by 264
Epidemiology of Acute Infections among Patients with Chronic Kidney Disease
Dalrymple, L. S., & Go, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01290308 · Cited by 254
Where does a Staphylococcus aureus vaccine stand?
Fowler, V. G., & Proctor, R. A. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12570 · Cited by 241
“02) [58].”
MethodResultInfluentialMoellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236
Progress Toward a Staphylococcus aureus Vaccine
Daum, R. S., & Spellberg, B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir828 · Cited by 165
McNeely, T. B., Shah, N. A., Fridman, A., Joshi, A., Hartzel, J. S., Keshari, R. S., Lupu, F., & DiNubile, M. J. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.34407 · Cited by 99
Harro, C., Betts, R., Orenstein, W., Kwak, E.-J., Greenberg, H. E., Onorato, M. T., Hartzel, J., Lipka, J., DiNubile, M. J., & Kartsonis, N. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00356-10 · Cited by 57
“V710 (5 g) 9/31 29 14, 48 3/31 10 2, 26 51 (39, 66) 1.”
Result
Metadata
- Authors
- Shinefield, H., Black, S., Fattom, A., Horwith, G., Rasgon, S., Ordonez, J., Yeoh, H., Law, D., Robbins, J. B., Schneerson, R., Muenz, L., Fuller, S., Johnson, J., Fireman, B., Alcorn, H., & Naso, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-02-14
- Volume
- 346
- Issue
- 7
- Pages
- 491-496
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2027988203
- Cited by
- 474
- References
- 14
- FWCI
- 21.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.